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Coxiella burnetii is the etiological agent of Q fever. To identify its major seroreactive proteins, a subgenomic protein array was 
developed. A total of 101 assumed virulence-associated recombinant proteins of C. burnetii were probed with sera from mice 
experimentally infected with C. burnetii and sera from Q fever patients. Sixteen proteins were recognized as major seroreactive 
antigens by the mouse sera. Seven of these 16 proteins reacted positively with at least 45% of Q fever patient sera. Notably, 
HspB had the highest fluorescence intensity value and positive frequency of all the proteins on the array when probed with 
both Q fever patient sera and mouse sera. These results suggest that these seven major seroreactive proteins, particularly HspB, 
are potential serodiagnostic and subunit vaccine antigens of Q fever. 
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Coxiella burnetii, the etiological agent of coxiellosis or Q 
fever, is an intracellular, acidophilic, gram-negative bacte-
rium, which replicates within the phagolysosome of the 
eukaryotic monocytes and macrophages [1,2]. However, it 
can now be grown axenically in a defined medium [3]. Ease 
of aerosol dissemination, environmental persistence, and 
high infectivity [4] make C. burnetii a serious threat to hu-
mans and as such it has been classified as a category B bio-
terrorism agent [5]. Q fever is a worldwide disease with 
acute and chronic stages in humans. Acute Q fever mani-
fests as a flu-like illness with high fever, fatigue, and chills, 
often accompanied by severe headaches. Serious complica-
tions and even death can occur in patients with acute Q fe-
ver, particularly in those with meningoencephalitis or myo-
carditis, and in chronic Q fever patients with endocarditis. 
An efficacious and safe vaccine and a specific and sensi-
tive serodiagnostic test are required for prevention and con-
trol of coxiellosis. Q-Vax, the Q fever vaccine licensed in 
Australia, is highly efficacious in prevention of the disease 
by inducing robust humoral and cell-mediated immune re-
sponses to C. burnetii [6]. However, severe local and occa-
sionally systemic adverse reactions to this vaccine have 
been observed, particularly among individuals previously 
sensitized to C. burnetii [7]. The diagnosis of human Q fe-
ver is mainly based on clinical presentation and serological 
responses against whole-cell phase I and phase II antigens 
of C. burnetii. Unfortunately, the complex nature of the 
whole-cell antigens of C. burnetii results in a lack of uni-
formity in test results [8]. Both microimmunofluorescence 
serological tests and Q fever vaccines contain intact organ-
isms of C. burnetii that contain many antigens. 
Investigation of C. burnetii antigens by various molecu-
lar methods could be a valuable research tool for the devel-
opment of novel approaches for detecting C. burnetii infec-
tion in clinical samples. Recently, several immunoproteo-
mic studies have reported the identification of such candi-
date protein antigens [9]. Moreover, many studies have also 
confirmed that the protein microarray approach is a feasible, 
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comprehensive, and high-throughput analysis tool for the 
elucidation of humoral immune responses to bacterial anti-
gens, and enables the discovery of potential antigens for 
diagnosis and vaccine development [10–12]. 
In this study, using genome sequence analysis of C. bur-
netii (Nine Mile, RSA493) [13], genes encoding proteins 
implicated in adhesion, invasion, intracellular trafficking, 
host modulation, detoxification, and other putative viru-
lence-related functions (Table S1) were selected for expres-
sion in prokaryotic cells. One hundred and one of the se-
lected genes were expressed successfully as recombinant 
proteins in Escherichia coli cells BL21 and subsequently 
produced as a microarray. The recombinant proteins on the 
microarray were systematically screened with mouse and 
human Q fever sera. 
1  Materials and methods 
1.1  Organism cultivation and chromosomal DNA iso-
lation 
The phase I strains of C. burnetii (Nine Mile and Xinqiao) 
[14] were propagated in chicken embryo yolk-sac as de-
scribed previously [15]. Chromosomal DNA was extracted 
directly from the infected yolk-sac membranes using the 
DNeasy Blood & Tissue Kit (Qiagen GmbH, Hilden, Ger-
many). The extracted DNA was used as the template for the 
amplification of C. burnetii genes by polymerase chain re-
action (PCR). 
1.2  Sera of mice infected with C. burnetii 
Forty BALB/c mice (7-week old males) were intraperitone-
ally inoculated with C. burnetii Xinqiao strain (107 organ-
isms per mouse), and 10 mice were randomly chosen and 
sacrificed on days 7, 14, 21, and 28 post-infection (pi). The 
sera from each group were pooled. The Beijing Administra-
tive Committee for Laboratory Animals approved the ani-
mal usage. 
1.3  Sera of patients 
Sixty-nine Q fever patient sera from various stages of infec-
tion were provided by the Australian Rickettsial Reference 
Laboratory (Geelong, VIC, Australia). Patients were diag-
nosed using an in-house C. burnetii immunofluorescence 
assay (IFA). According to the results of IFA and clinical 
symptoms, the Q fever antibody positive (QAb-positive) 
sera were classified into 3 types, acute, chronic, and past. 
The acute sera were further classified into 3 subtypes, early, 
late, and convalescent. Nine sera from patients diagnosed 
with early stage acute Q fever were Q fever antibody nega-
tive (QAb-negative) in IFA and these were used as negative 
controls in the protein array. This study was approved by 
the ethics committee of the Beijing Institute of Microbiolo-
gy and Epidemiology. The serum samples of patients were 
collected as part of the routine management of patients and 
all patient data were anonymized. 
1.4  Preparation of assumed virulence-associated re-
combinant proteins 
One hundred and fifty-six open reading frames (ORFs), 
which were assumed to be associated with bacterial viru-
lence, were selected from the C. burnetii Nine Mile strain 
(RSA493) genome sequence (accession number NC_ 
002971). According to the genome annotation of C. burnetii 
in GenBank, a reductive strategy was employed to remove 
genes encoding proteins present in non-pathogens and 
housekeeping genes, whilst retaining genes that code for 
known or suspected virulence-associated proteins (Table 
S1). The genes encoding these virulence-associated proteins 
were amplified with primer pairs designed with Primer 5.0 
software (Table S2). Adapter sequences homologous to the 
cloning sites of pET-32a prokaryotic expression plasmid 
were added to the primers which allowed cloning of the 
PCR products into the expression plasmid. 
The amplified target gene fragments were purified from 
agarose gels using a DNA purification kit (Qiagen) and li-
gated to the pET-32a vector (Novagen, Madison, WI, USA) 
as per the manufacturer’s instructions. Competent cells (E. 
coli BL21) were transformed with the plasmids and 
screened on agar plates containing ampicillin according to 
standard procedures [16]. Positive clones were cultured in 
liquid LB and induced with isopropyl-β-D-thiogalactoside 
(IPTG; Sigma, Louis, MO, USA) to express the recombi-
nant proteins. Following IPTG induction, bacteria were pel-
leted by centrifugation and suspended in 10 mmol L1 
Tris-HCl buffer (pH 8.0). The bacteria were mixed with an 
equal volume of 2× sodium dodecyl sulfate (SDS) sample 
buffer and boiled for 10 min. The proteins were separated 
by electrophoresis on 12% (w/v) SDS-polyacrylamide gels 
(SDS-PAGE) and stained with Coomassie blue. 
1.5  Microarray fabricated with recombinant proteins 
The recombinant proteins were purified using Ni-NTA resin 
(Qiagen) according to the manufacturer’s protocol. The 
concentration of the purified proteins was determined using 
a BCA protein assay reagent kit (Pierce, Rockford, MN, 
USA) and adjusted to approximately 150 μg mL1 with 250 
mmol L1 imidazole [17]. The purified proteins were printed 
in triplicate spots onto aldehyded glass slides (CEL, Pear-
land, TX, USA) to create a protein array. The cell lysate of 
E. coli BL21 transformed with pET-32a plasmid was print-
ed as a negative control and mouse immunoglobulin G (IgG) 
or human IgG was printed as a positive control. The printed 
slides were incubated at room temperature for at least 1 h 
and then stored at 4°C. For quality control, the proteins 
were incubated with the Cy5-conjugated anti-His mouse 
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IgG on the array. Only the proteins with a signal-to-   
background ratio of 3.0 were used for further analysis. 
1.6  Detection of seroreactive proteins 
To minimize background reactivity, all sera were diluted 
1:200 in PBS buffer (pH 7.2) containing 2% (w/v) bovine 
serum albumin (BSA). Non-specific interactions were fur-
ther reduced by incubating the sera for 2 h with the debris of 
the IPTG induced cells carrying pET32a. The arrays were 
blocked with PBS containing 1% (w/v) BSA at room tem-
perature for 60 min, and then incubated with the absorbed 
sera for 12 h at 4°C. The arrays were washed five times in 
wash buffer (PBS containing 0.05% (w/v) Tween 20). For 
detection of reactivity, Cy5-conjugated goat anti-mouse IgG 
(Southern Biotech, Birmingham, UK) diluted 1:500 in PBS 
containing 1% (w/v) BSA and Cy5-conjugated goat an-
ti-human IgG (Jackson Immunoresearch, West Grove, PA, 
USA) diluted 1:200 were added to their respective assays 
and incubated at 37°C for 45 min. After three wash buffer 
rinses, three PBS rinses and one final water wash, the arrays 
were air-dried for 30 min and then scanned with a Per-
kin-Elmer ScanArray Express HT apparatus (PerkinElmer, 
Covina, CA, USA) at a wavelength of 630 nm and with an 
RGB format TIFF file output. 
1.7  Data analysis 
The scanned images were analyzed by the GenePix pro 5.1 
software (Axon Instruments, Union, CA, USA). The fluo-
rescence intensity (FI) of each protein was calculated by 
averaging the FIs of three replicate spots with their back-
ground fluorescence subtracted. The FIs obtained from dif-
ferent arrays were normalized based on the FIs of the posi-
tive controls and displayed with TreeView software [18]. 
The significance of differences between samples collected 
from the groups of mice or patients were determined by an 
exact Wilcoxon signed rank test using SPSS 16 software 
(IBM, Armonk, NY, USA) [19]. 
2  Results 
2.1  Development of a protein array assay using C. 
burnetii proteins 
One hundred and fifty-six genes encoding proteins impli-
cated in adhesion, invasion, intracellular trafficking, host 
modulation, detoxification, and other virulence-related 
functions were selected for the protein array. One hundred 
and seventy-three pairs of primers were designed to amplify 
the 156 genes (Table S2). Because of the large size of 17 
target genes with sequence lengths greater than 2000 bp, 
amplicons were divided into two fragments for total gene 
coverage (Table S2). One hundred and fifty-five of the 173 
amplified gene fragments were successfully cloned into the 
pET-32a plasmids and 104 were efficiently expressed as 
recombinant proteins in E. coli cells. Using nickel-ion affin-
ity chromatography (Ni-NTA), 104 recombinant proteins 
were purified from the cellular materials of the transformed 
bacteria. These expressed proteins were printed onto an 
aldehyde slide by the SpotArrayTM24 robot to create a sub-
genomic protein array. One hundred and one proteins giving 
a signal-to-background ratio of 3.0 were thought to be ac-
ceptable for further analysis. 
2.2  Seroreactive proteins identified with mouse sera 
The 101 proteins on the array were probed with sera from 
BALB/c mice that had been experimentally infected with C. 
burnetii. The proteins were considered to be seroreactive if 
their FIs were six-fold higher than those recorded for nor-
mal mouse sera [20]. As a result, 2, 66, 84, and 75 of the 
101 proteins were recognized as seroreactive by mouse sera 
obtained at days 7, 14, 21, and 28 pi, respectively. Among 
these seroreactive proteins, 15 had stronger FIs than that of 
Coxiella outer membrane protein 1 (Com1) [21], when 
probed with sera obtained on days 21 and 28 pi (Figure 1). 
2.3  Major seroreactive proteins identified with patient 
sera 
The 101 Coxiella proteins on the array were probed with Q 
fever patient sera. The average FI value of the proteins 
probed with QAb-negative sera was 83 (Table S3). The av-
erage FI value of the proteins probed with the sera from 
patients with early stage acute Q fever was 100 (Table S3), 
slightly higher than that of the negative control, The average 
FI value of the proteins probed with the sera from patients 
with late stage acute Q fever was 212 (Table S3), signifi-
cantly higher than that probed with early stage acute Q fever 
patient sera (P<0.05) (Figure 2). All the FI values from the  
 
 
Figure 1  Sixteen proteins on the array were strongly recognized by 
mouse sera obtained at days 7 (1 week), 14 (2 weeks), 21 (3 weeks), and 28 
(4 weeks) post infection with Coxiella burnetii. Normal sera from unin-
fected mice were used as negative controls. 
456 Wang X L, et al.   Sci China Life Sci   May (2013) Vol.56 No.5 
 
Figure 2  Overview of seroreactive proteins probed with sera from pa-
tients at different stages of Q fever infection. The x-axis indicates the dif-
ferent stages of Q fever, and the y-axis indicates the Ln-transformed FI 
values of each group of patients’ sera. 
tested sera are presented in Table S3. The average FI value 
of the proteins probed with sera from Q fever patients in 
their convalescent phase remained significantly higher than 
that probed with QAb-negative sera (P<0.05), but generally 
lower than that probed with sera taken during the late stage 
of acute Q fever infection (Figure 2). The average FI value 
of the proteins probed with chronic or past Q fever patient 
sera was not significantly different from that probed with 
the QAb-negative sera (P>0.05), but the FI values of certain 
individual proteins, particularly heat shock protein B 
(HspB), were markedly higher than that probed with QAb- 
negative sera (Table 1). 
The FI mean and standard deviation (SD) of each protein 
probed with QAb-negative and QAb-positive sera were 
calculated. Proteins were considered to be positively sero-
reactive when the FI mean value for the QAb-positive sera 
was 2SD above that of the QAb-negative sera. Using these 
criteria, seven proteins, HspB, Ank4, Ank2, ApaH, EnhA, 
IcmO, and BipA, were positively recognized by more than 
45% of QAb-positive sera from patients with late stage 
acute Q fever. The positive frequency of HspB probed with 
sera from patients with late stage acute Q fever was 85%. 
The FI value of HspB probed with sera from patients with 
early stage acute Q fever and chronic Q fever was over 100- 
and 200-fold higher, respectively, than that probed with the 
QAb-negative sera (Table 1).  
2.4  Analysis of recombinant proteins with paired acute 
Q fever patient sera 
The seven major seroreactive proteins of C. burnetii recog-
nized by sera of patients with Q fever were analyzed with 
two groups of paired sera from patients with acute Q fever. 
In the first group examined, each patient had an acute 
specimen that was QAb-negative and a convalescent speci-
men that was QAb-positive, showing seroconversion (Fig-
ure 3A). In the second group, each patient had both an acute  
 
 
Figure 3  Coxiella major seroreactive proteins probed with paired Q fever 
patient sera. The convalescent sera were collected from the patients 522 
days after the first sampling. A, In the first group, each protein was probed 
with seven pairs of acute (QAb-negative) and convalescent (QAb-positive) 
sera. B, In the second group, each protein was probed with seven pairs of 
acute (QAb-positive) and convalescent (QAb-positive) sera. The average 
FI of each protein probed with the convalescent sera was significantly 
higher than that of the acute sera (P<0.05). 
Table 1  The average FI of each major seroreactive protein on the array probed with sera of patients with Q fevera) 
Gene ID  Protein 
Sera of patients with acute Q fever Sera of patients with 
Ab- 
negative 







CBU1718 HspB 12 1819 4 2367 17 1749 3 2698 6 276 5 
CBU0447 Ank4 43 44 2 380 12 114 4 67 2 44 2 
CBU1987 ApaH 52 84 2 265 10 157 2 99 2 23 1 
CBU0884 BipA 181 132 0 473 9 295 3 104 0 154 2 
CBU0201 Ank2 398 307 3 1410 9 1114 4 480 2 687 2 
CBU0053 EnhA3 362 499 1 885 9 618 4 344 1 387 1 
CBU1632 IcmO 97 56 0 261 9 213 4 124 1 114 3 
Average 164 420 1.7 863 10.7 609 3.4 559 2 241 2.3 
a) “n” indicates the number of the serum samples used in probing. 
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and convalescent specimen that was QAb-positive (Figure 
3B). The relative FI values were analyzed using an exact 
Wilcoxon signed rank test. The result showed that the FI 
value of each of the seven proteins probed with acute sera 
were significantly lower than those of the convalescent sera 
(P<0.05) (Figure 3, Table S4). 
3  Discussion 
The availability of the complete genome sequence of C. 
burnetii has contributed significantly to our understanding 
of the biology and pathogenesis of this organism [13]. As-
says based on two-dimensional gel resolution of endoge-
nous antigens are able to identify seroreactive proteins of C. 
burnetii [2224], but the lack of equal antigen representa-
tion in the organism and the denaturation of proteins during 
the procedure restrict the usefulness of this method for iden-
tification of these proteins. One hundred and fifty-six genes 
that encode proteins with potential roles in adhesion, inva-
sion, intracellular trafficking, host modulation, detoxifica-
tion, or other virulence-related functions were selected in 
this study [13]. The recombinant virulence-associated pro-
teins were used to develop a subgenomic protein array of C. 
burnetii. The Coxiella proteins on the array were probed 
with sera from mice experimentally infected with C. bur-
netii and Q fever patient sera. These sera have collectively 
allowed novel seroreactive antigens to be identified. 
The proteins on the array were screened with mouse Q 
fever sera from different time points after C. burnetii infec-
tion. An increase in reactivity of some of these proteins was 
observed with convalescent bleeds. This result showed that 
these proteins had the ability to evoke a humoral immune 
response and yield specific antibodies whose reactivity in-
creased gradually with the progression of the infection. In 
addition, 15 proteins on the array had higher FI values than 
the Coxiella outer membrane protein 1 (Com1), which is the 
first surface protein antigen of C. burnetii recognized by Q 
fever sera [21]. This suggests that these proteins might be 
major seroreactive antigens of C. burnetii. 
It is possible that any given response in mice may not 
occur in precisely the same way as in humans because of 
significant differences between mouse and human immu-
nology [25]. Therefore, it was necessary to probe these pro-
teins with human Q fever sera to understand the humoral 
immune responses induced by the virulence-associated pro-
teins in Q fever patients. The Coxiella proteins on this array 
were probed with patient sera from different stages of infec-
tion, including acute (early, late and convalescent), chronic 
and past Q fever. The average FI value of the proteins 
probed with late stage acute Q fever patient sera was signif-
icantly higher than that probed with early stage acute Q fe-
ver patient sera. This indicated that the level of specific an-
tibodies to most of the virulence-associated proteins rose 
markedly as the acute disease progressed to the later stage. 
Although the FI values of these proteins on the array gener-
ally declined with sera from the convalescent stage com-
pared with the late stage sera, the average FI value remained 
significantly higher than that of the QAb-negative sera. This 
result indicates ongoing persistence of these antibodies dur-
ing the course of acute infection. 
The average FI value of the proteins probed with either 
chronic or past Q fever sera was not significantly different 
from that probed with QAb-negative sera. However, the FI 
values of some individual proteins, particularly HspB, were 
significantly higher than those of the QAb-negative sera. In 
addition, a further six recombinant proteins, Ank4, Ank2, 
ApaH, EnhA, IcmO, and BipA, were all recognized by both 
patient and mouse sera. These antigens may therefore be 
useful as potential diagnostic and vaccine candidates. To 
further characterize the major seroreactive antigens, the 
seven proteins were analyzed using paired Q fever sera. The 
FI value of each protein probed with the first serum was 
significantly lower than that probed with the second serum 
from the same patient, which suggested that these seven 
Coxiella proteins can stimulate the human immune re-
sponses to generate high levels of specific antibodies.  
In our previous immunoproteomic analysis [26], only 
HspB was recognized as a major seroreactive antigen. We 
postulate that the six additional proteins identified in the 
current study are less abundant in the bacterial cells than 
those identified in our previous study. This may explain 
why they were not recognized by the human Q fever sera in 
immunoblot analysis. In addition, five seroreactive antigens 
(one hypothetical protein (CBU0891), OmpH (CBU0612), 
YajC (CBU1143), SucB (CBU1398), and LemA (CBU0545)) 
of C. burnetii were identified previously in two protein mi-
croarrays containing 84% and 75% of the ORFs of C. bu-
rentii [27,28]. These antigens were not included in this 
study but should be included in any future work. 
HspB is located in the bacterial surface and periplasm, 
and is a member of the surface-associated Hsp60 family that 
is involved in bacterial virulence [29,30]. HspB of C. bur-
netii was previously characterized [31] and recognized as an 
immunodominant antigen [6,26] and as an immunodiagnos-
tic antigen of ruminant coxiellosis [32]. In this study, the 
frequencies of positive reactivity to HspB probed with con-
valescent and chronic Q fever patient sera were markedly 
higher than that reported previously. Notably, the average 
FI values of HspB probed with sera from patients with acute 
and chronic Q fever were both significantly higher than 
QAb-negative sera. These results strongly suggest that 
HspB is an excellent molecular marker for serodiagnosis in 
both acute and chronic Q fever. 
Ankyrin repeat domain proteins (Anks) are included in a 
protein family that shows remarkable heterogeneity 
amongst different isolates of C. burnetii. They are translo-
cated into the host cytosol in a Dot/Icm-dependent fashion 
to modulate diverse functions in host cells [33]. In this 
study, Ank4 Ank2, Ank11, and Ank6 were recognized at 
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various frequencies by the late stage acute Q fever patient 
sera, which indicated that the patients either lacked, or had a 
variable response to, a variety of Ank proteins. ApaH is a 
diadenosine tetraphosphatase associated with bacterial fim-
brial biosynthesis, carbohydrate utilization, catabolite (CRP- 
cAMP) regulation and cell division and probably affects 
virulence phenotypes such as invasion and adhesion [34,35]. 
BipA is a tyrosine-phosphorylated GTPase that mediates 
interactions between enteropathogenic E. coli (EPEC) and 
epithelial cells [36]. EnhA, a type IV secretion-independent 
virulence factor, has an invasion-associated trait because it 
contains multiple copies of the protein-protein interaction 
domain Sel-1 that affects the initial encounter with host 
cells [37]. IcmO belongs to the Icm/Dot pathogenesis sys-
tems of C. burnetii. These virulence-associated proteins 
were recognized by more than 45% of sera from patients 
with late stage acute Q fever. 
When the proteins were analyzed in combination, 95% of 
patients with late stage Q fever responded to one or more of 
the seven major seroreactive antigens, suggesting that they 
are potential serodiagnostic markers of Q fever. However, 
their sensitivity and specificity in actual diagnosis and their 
specific protective efficacy in animal models still need to be 
evaluated further to determine their suitability as serodiag-
nostic and subunit vaccine antigens of Q fever.  
4  Conclusion 
A subgenomic protein array was developed with 101 as-
sumed virulence-associated proteins of C. burnetii. The 
array was probed with sera from mice experimentally in-
fected with C. burnetii. Sixteen proteins were recognized as 
major seroreactive proteins. Seven of the major immunore-
active proteins, HspB, Ank4, Ank2, ApaH, EnhA, IcmO, 
and BipA, were recognized by at least 45% of sera from 
patients with the late stage acute Q fever. The dominance of 
HspB as a major seroreactive protein was confirmed. 
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